Samsung Biologics ranked among the top searched stocks for 12 days in the past month.

As of 12:32 PM on the 17th, Samsung Biologics is trading at 820,000 KRW, down 0.73% from the previous day. This represents a 36.67% increase compared to May 20. Samsung Biologics is known as the holding company for Samsung Group's bio business.

Today, foreigners have a net purchase of 2,000 shares of Samsung Biologics, and institutions also have a net purchase of 2,000 shares, according to provisional data. Over the past five days, individual investors have net sold 40,819 shares, while foreigners and institutions have net bought 25,807 shares and 219 shares, respectively.

On June 15, Samsung Biologics was a market topic with the headline "Record High... Five Consecutive Days of Gains."



[Table] Net Trading Volume of Foreigners and Institutions (Unit: shares)
※Source: AI Investment Assistant AI Rassiro

※ This article was generated in real-time by an automated article creation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.



This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing